Assessment of vitamin B12 levels and cardiovascular risk factors in metformin- and non-metformin-treated type 2 diabetic patients. 2023

Kinga Ilona Nyulas, and Mariana Cornelia Tilinca, and Sándor Pál, and Erzsébet Májai Fogarasi, and Mircea Dumitru Croitoru, and Robert Gabriel Tripon, and Zoltán Preg, and Márta Germán-Salló, and Zsuzsánna Simon-Szabó, and Enikő Nemes-Nagy
George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureş, Romania.

Oxidative stress enhances cardiovascular risk. Metformin decreases intestinal absorption of vitamin B12. Our objective was the evaluation of type 2 diabetics focusing on differences due to their treatment. A prospective study on 224 type 2 diabetics was realized between 2015-2018 in Targu Mures, Romania, divided into 2 subgroups (metformin vs. other therapy - 2nd/3rd generation sulfonylureas, insulin, dietary regimen -, followed for at least one year) and non-diabetic controls (n=25) for oxidative stress level comparison. Serum homocysteine (HC), vitamin B12 were determined by chemiluminescence (Immulite One). Lipid peroxidation was assessed by serum malondialdehyde (MDA) measurement (HPLC). Biochemical tests, minerals, cystatin C, high-sensitivity C reactive protein (hs-CRP) were measured on Konelab20Xti, glycated hemoglobin on Nycocard Reader. GraphPad InStat-3 was used for statistics. Negative correlation occured between serum vitamin B12 and HC, this vitamin's level was significantly lower and serum zinc was significantly higher in patients on metformin. Hyperhomocysteinemia was present in 87% of the subjects, 46% had zinc deficiency and 41% elevated hs-CRP. Serum cystatin C showed positive correlation with creatinine. Serum MDA was significantly higher in diabetics compared to control patients. Elevated hs-CRP and homocysteine represent raised cardiovascular risk. Intense oxidative stress, vitamin, mineral deficiencies are frequent in diabetic subjects.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008687 Metformin A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) Dimethylguanylguanidine,Dimethylbiguanidine,Glucophage,Metformin HCl,Metformin Hydrochloride,HCl, Metformin,Hydrochloride, Metformin
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D006710 Homocysteine A thiol-containing amino acid formed by a demethylation of METHIONINE. 2-amino-4-mercaptobutyric acid,Homocysteine, L-Isomer,2 amino 4 mercaptobutyric acid,Homocysteine, L Isomer,L-Isomer Homocysteine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000082742 Heart Disease Risk Factors Aspects of personal behavior or lifestyle, environmental exposure, inherited conditions and characteristics, which are determined to be associated with HEART DISEASES. Cardiovascular Risk,Cardiovascular Risk Factors,Cardiovascular Risk Score,Residual Cardiovascular Risk,Risk Factors for Cardiovascular Disease,Risk Factors for Heart Disease,Cardiovascular Risk Factor,Cardiovascular Risk Scores,Cardiovascular Risk, Residual,Cardiovascular Risks,Factor, Cardiovascular Risk,Residual Cardiovascular Risks,Risk Factor, Cardiovascular,Risk Score, Cardiovascular,Risk, Cardiovascular,Risk, Residual Cardiovascular,Score, Cardiovascular Risk
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

Kinga Ilona Nyulas, and Mariana Cornelia Tilinca, and Sándor Pál, and Erzsébet Májai Fogarasi, and Mircea Dumitru Croitoru, and Robert Gabriel Tripon, and Zoltán Preg, and Márta Germán-Salló, and Zsuzsánna Simon-Szabó, and Enikő Nemes-Nagy
June 2023, Chronic illness,
Kinga Ilona Nyulas, and Mariana Cornelia Tilinca, and Sándor Pál, and Erzsébet Májai Fogarasi, and Mircea Dumitru Croitoru, and Robert Gabriel Tripon, and Zoltán Preg, and Márta Germán-Salló, and Zsuzsánna Simon-Szabó, and Enikő Nemes-Nagy
March 2022, Cureus,
Kinga Ilona Nyulas, and Mariana Cornelia Tilinca, and Sándor Pál, and Erzsébet Májai Fogarasi, and Mircea Dumitru Croitoru, and Robert Gabriel Tripon, and Zoltán Preg, and Márta Germán-Salló, and Zsuzsánna Simon-Szabó, and Enikő Nemes-Nagy
January 2021, PloS one,
Kinga Ilona Nyulas, and Mariana Cornelia Tilinca, and Sándor Pál, and Erzsébet Májai Fogarasi, and Mircea Dumitru Croitoru, and Robert Gabriel Tripon, and Zoltán Preg, and Márta Germán-Salló, and Zsuzsánna Simon-Szabó, and Enikő Nemes-Nagy
December 2015, Annals of Ibadan postgraduate medicine,
Kinga Ilona Nyulas, and Mariana Cornelia Tilinca, and Sándor Pál, and Erzsébet Májai Fogarasi, and Mircea Dumitru Croitoru, and Robert Gabriel Tripon, and Zoltán Preg, and Márta Germán-Salló, and Zsuzsánna Simon-Szabó, and Enikő Nemes-Nagy
October 2012, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion,
Kinga Ilona Nyulas, and Mariana Cornelia Tilinca, and Sándor Pál, and Erzsébet Májai Fogarasi, and Mircea Dumitru Croitoru, and Robert Gabriel Tripon, and Zoltán Preg, and Márta Germán-Salló, and Zsuzsánna Simon-Szabó, and Enikő Nemes-Nagy
September 2020, Acta diabetologica,
Kinga Ilona Nyulas, and Mariana Cornelia Tilinca, and Sándor Pál, and Erzsébet Májai Fogarasi, and Mircea Dumitru Croitoru, and Robert Gabriel Tripon, and Zoltán Preg, and Márta Germán-Salló, and Zsuzsánna Simon-Szabó, and Enikő Nemes-Nagy
January 2019, SAGE open medicine,
Kinga Ilona Nyulas, and Mariana Cornelia Tilinca, and Sándor Pál, and Erzsébet Májai Fogarasi, and Mircea Dumitru Croitoru, and Robert Gabriel Tripon, and Zoltán Preg, and Márta Germán-Salló, and Zsuzsánna Simon-Szabó, and Enikő Nemes-Nagy
August 2006, Journal of clinical pharmacy and therapeutics,
Kinga Ilona Nyulas, and Mariana Cornelia Tilinca, and Sándor Pál, and Erzsébet Májai Fogarasi, and Mircea Dumitru Croitoru, and Robert Gabriel Tripon, and Zoltán Preg, and Márta Germán-Salló, and Zsuzsánna Simon-Szabó, and Enikő Nemes-Nagy
April 2023, La Tunisie medicale,
Kinga Ilona Nyulas, and Mariana Cornelia Tilinca, and Sándor Pál, and Erzsébet Májai Fogarasi, and Mircea Dumitru Croitoru, and Robert Gabriel Tripon, and Zoltán Preg, and Márta Germán-Salló, and Zsuzsánna Simon-Szabó, and Enikő Nemes-Nagy
February 2024, Irish journal of medical science,
Copied contents to your clipboard!